Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 15.8B | 16.0B | 16.3B | 14.9B |
Cost of revenue | 10.4B | 11.0B | 11.0B | 10.0B |
Gross profit | 5.5B | 5.1B | 5.2B | 4.9B |
Operating expense | ||||
Research & development | 741M | 708M | 718M | 677M |
Selling general and admin | 1.7B | 1.7B | 1.6B | 1.5B |
Other operating expenses | — | — | — | — |
Operating income | 3.0B | 2.7B | 2.9B | 2.7B |
Non operating interest income | ||||
Income | 87M | 60M | 15M | 17M |
Expense | 70M | 80M | 66M | 56M |
Other income expense | -203M | -389M | -158M | -281M |
Pretax income | 2.8B | 2.3B | 2.7B | 2.4B |
Tax provision | -397M | 364M | 306M | 123M |
Net income | 3.2B | 1.9B | 2.4B | 2.3B |
Basic EPS | 10.4 | 6.1 | 7.5 | 6.9 |
Diluted EPS | 10.3 | 6.0 | 7.5 | 6.8 |
Basic average shares | 307M | 315M | 323M | 330M |
Diluted average shares | 307M | 315M | 323M | 330M |
EBITDA | 3.9B | 3.5B | 3.8B | 3.5B |
Net income from continuing op. | 3.2B | 1.9B | 2.4B | 2.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |